Cuba vs Montenegro: HIV-positive TB patients on ART (antiretroviral therapy)
Cuba
100.0%
in 2024
Montenegro
100.0%
in 2023
Cuba rank
1st
Montenegro rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Cuba
- Montenegro
How they compare
Cuba currently reports 100.0% against 100.0% in Montenegro, a difference of 0.0%.
The two have swapped places 2 times across 6 shared years of data; in 2006 it was Montenegro ahead.
Cuba ranks 1st and Montenegro ranks 1st of 144 countries.
Across the 3 decades both report, Cuba averaged higher in 1 and Montenegro in 1.
Head to head by decade
| Decade | Cuba | Montenegro | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 100.0% | 0.0% | — |
| 2010s | 75.3% | 100.0% | 24.7% | Montenegro |
| 2020s | 100.0% | 75.0% | 25.0% | Cuba |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Cuba or Montenegro?
- Cuba, at 100.0% against 100.0% in Montenegro as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Cuba and Montenegro?
- 0.0%, with Cuba ahead.
- How many years of comparable data are there for Cuba and Montenegro?
- 6 years are reported by both, from 2006 to 2023.
- How do Cuba and Montenegro rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Cuba ranks 1st and Montenegro ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.